Published in Bone on February 01, 2001
The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int (2012) 1.26
Mapping of the minimal inorganic phosphate transporting unit of human PiT2 suggests a structure universal to PiT-related proteins from all kingdoms of life. BMC Biochem (2011) 1.18
Role of matrix vesicles in biomineralization. Biochim Biophys Acta (2009) 1.17
Biomineralization and matrix vesicles in biology and pathology. Semin Immunopathol (2010) 1.14
The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development. PLoS One (2010) 1.11
Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today (2008) 0.90
Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1. Cell Div (2012) 0.88
Mice with hypomorphic expression of the sodium-phosphate cotransporter PiT1/Slc20a1 have an unexpected normal bone mineralization. PLoS One (2013) 0.83
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1. Sci Rep (2016) 0.79
Novel early response genes in osteoblasts exposed to dynamic fluid flow. Philos Trans A Math Phys Eng Sci (2010) 0.78
Alpha Klotho and phosphate homeostasis. J Endocrinol Invest (2014) 0.78
Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte-Derived Matrix Vesicles in Phospho1(-/-) and Phospho1/Pi t1 Double-Knockout Mice. J Bone Miner Res (2016) 0.76
Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database Syst Rev (2000) 3.46
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients. Aliment Pharmacol Ther (2014) 3.37
New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure (1999) 2.92
Impact of payment method on behaviour of primary care physicians: a systematic review. J Health Serv Res Policy (2001) 2.67
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
How should we pay doctors? A systematic review of salary payments and their effect on doctor behaviour. QJM (1999) 2.26
Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol (1993) 2.22
The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther (2015) 2.16
Idiopathic bile acid catharsis. Gut (1976) 2.11
Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol (2014) 2.04
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Chronic liver disease and 90-day mortality in 21,359 patients following peptic ulcer bleeding--a Nationwide Cohort Study. Aliment Pharmacol Ther (2015) 2.01
Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature (1981) 1.97
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J Virol (1991) 1.92
Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage (2001) 1.91
Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost (2007) 1.89
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Balpha. Mol Cell (2000) 1.78
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med (2010) 1.71
Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA. J Virol (1980) 1.69
Long-term effects of migraine on cognitive function: a population-based study of Danish twins. Neurology (2005) 1.65
Crystal structures of nucleotide exchange intermediates in the eEF1A-eEF1Balpha complex. Nat Struct Biol (2001) 1.62
Target payments in primary care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 1.59
Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus. J Virol (1995) 1.59
Influences of solvent water on protein folding: free energies of solvation of cis and trans peptides are nearly identical. Biochemistry (1988) 1.51
The nucleotide sequence of the Akv murine leukemia virus genome. Virology (1984) 1.51
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol (1993) 1.50
Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology (2001) 1.43
Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice. J Intern Med (2002) 1.43
Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand (2000) 1.43
Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis (2006) 1.39
Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J Virol (1992) 1.37
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. Proc Natl Acad Sci U S A (1980) 1.36
Rapid screening of increased bile acid deconjugation and bile acid malabsorption by means of the glycine-l-(14C) cholylglycine assay. Scand J Gastroenterol (1973) 1.33
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol (2002) 1.29
Sequence and genetic analysis of the hemin storage (hms) system of Yersinia pestis. Gene (1997) 1.26
Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J Virol (1989) 1.25
Diarrhoea associated with idiopathic bile acid malabsorption. Fact or fantasy? Dan Med Bull (1973) 1.25
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer (2008) 1.22
Analysis of the relA gene product of Escherichia coli. Eur J Biochem (1977) 1.22
Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer (2005) 1.22
Visual, auditory and somatosensory pathway involvement in hereditary cerebellar ataxia, Friedreich's ataxia and familial spastic paraplegia. Electroencephalogr Clin Neurophysiol (1981) 1.21
Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene. Gene (1989) 1.18
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus. J Virol (1980) 1.16
A linkage study of hereditary ataxias and related disorders. Evidence of heterogeneity of dominant cerebellar ataxia. Hum Genet (1980) 1.14
Increased cloning efficiency by temperature-cycle ligation. Nucleic Acids Res (1996) 1.14
Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med (2009) 1.14
Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy (2007) 1.14
Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene (2000) 1.13
Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J Virol (1996) 1.12
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care (1985) 1.10
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J Virol (1997) 1.07
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo. J Virol (1997) 1.06
Isolation of a lambda transducing bacteriophage carrying the relA gene of Escherichia coli. J Bacteriol (1976) 1.05
Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut (2003) 1.05
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther (1998) 1.04
B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J Virol (1998) 1.04
Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts. J Med Chem (1987) 1.04
Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol (1990) 1.04
Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol (2000) 1.03
Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology (2005) 1.03
Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03
Crystal structure of human catecholamine sulfotransferase. J Mol Biol (1999) 1.01
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Molecular dynamics simulation of bovine prothrombin fragment 1 in the presence of calcium ions. Biochemistry (1992) 1.00
Codeine in analgesic doses does not depress respiration in patients with severe chronic obstructive lung disease. Pharmacol Toxicol (1990) 1.00
Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci (2000) 1.00
Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect (2013) 1.00
Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther (2003) 0.99
Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology (1990) 0.97
Efficient non-PCR-mediated overlap extension of PCR fragments by exonuclease "end polishing". Biotechniques (1997) 0.97
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol (2000) 0.96
Comparative analysis of RNA tumor virus genomes. Haematol Blood Transfus (1979) 0.96
Does month of birth affect risk of Crohn's disease in childhood and adolescence? BMJ (2001) 0.95
An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo. J Virol (1997) 0.95
Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers. Virology (2000) 0.95
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants. J Virol (1997) 0.94
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer (2002) 0.93
Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer (2011) 0.93
E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem (1996) 0.92
Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4. J Virol (1999) 0.92
First report of a de novo mutation at SLC20A2 in a patient with brain calcification. J Mol Neurosci (2014) 0.92
Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA (2001) 0.91
Mortality after discharge from the intensive care unit during the early weekend period: a population-based cohort study in Denmark. Acta Anaesthesiol Scand (2007) 0.91
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91
COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Aliment Pharmacol Ther (2004) 0.91
Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4. J Virol (2000) 0.90
Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study. Br J Cancer (2006) 0.90